Guillaume E. Béranger

1.4k total citations
28 papers, 939 citations indexed

About

Guillaume E. Béranger is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Guillaume E. Béranger has authored 28 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Physiology. Recurrent topics in Guillaume E. Béranger's work include Adipose Tissue and Metabolism (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Melanoma and MAPK Pathways (3 papers). Guillaume E. Béranger is often cited by papers focused on Adipose Tissue and Metabolism (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Melanoma and MAPK Pathways (3 papers). Guillaume E. Béranger collaborates with scholars based in France, Germany and Monaco. Guillaume E. Béranger's co-authors include Ez‐Zoubir Amri, Didier F. Pisani, Robert Ballotti, Corine Bertolotto, Dominique Langin, Georges F. Carle, J. C. Leclerc, Mansour Djedaini, Valentin Barquissau and Jean‐Claude Scimeca and has published in prestigious journals such as Nature Communications, Genes & Development and Scientific Reports.

In The Last Decade

Guillaume E. Béranger

28 papers receiving 933 citations

Peers

Countries citing papers authored by Guillaume E. Béranger

Since Specialization

Citations

This map shows the geographic impact of Guillaume E. Béranger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillaume E. Béranger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillaume E. Béranger more than expected).

Fields of papers citing papers by Guillaume E. Béranger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillaume E. Béranger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillaume E. Béranger. The network helps show where Guillaume E. Béranger may publish in the future.

Co-authorship network of co-authors of Guillaume E. Béranger

This figure shows the co-authorship network connecting the top 25 collaborators of Guillaume E. Béranger. A scholar is included among the top collaborators of Guillaume E. Béranger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillaume E. Béranger. Guillaume E. Béranger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies 2021 ·Cell Death and Disease ·Emilie Jaune, (unknown), Cyril Ronco, (unknown), Patricia Abbe, (unknown), (unknown), Guillaume E. Béranger, (unknown), Frédéric Bost, Maéva Gesson, Meri K. Tulić, Paul Hofman, Robert Ballotti, Thierry Passeron, Thomas Botton, Rachid Benhida, Stéphane Rocchi	19
2	CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3 2021 ·Journal of Investigative Dermatology ·Henri Montaudié, Laura Sormani, Bérengère Dadone‐Montaudié, M. Heim, Nathalie Cardot‐Leccia, Meri K. Tulić, Guillaume E. Béranger, Anne-Sophie Gay, Delphine Debayle, Yann Chéli, (unknown), Pierre Sohier, Valérie Petit, Stéphane Rocchi, Franck Gesbert, Lionel Larue, Thierry Passeron	4
3	FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells 2021 ·Cell Death and Differentiation ·(unknown), (unknown), Frédéric Soysouvanh, (unknown), Serena Giuliano, Sophie Nguyen, Pavel Hořák, Anne-Sophie Gay, Delphine Debayle, Nicolas Nottet, Guillaume E. Béranger, Brigitte Bressac–de Paillerets, Corine Bertolotto, Robert Ballotti	18
4	Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity 2021 ·Molecular Cancer ·Yann Chéli, Meri K. Tulić, (unknown), Nicolas Nottet, Arnaud Jacquel, Maéva Gesson, Thomas Strub, Karine Bille, (unknown), Henri Montaudié, Guillaume E. Béranger, Thierry Passeron, Pierre Close, Corine Bertolotto, Robert Ballotti	1
5	Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo 2019 ·Nature Communications ·Meri K. Tulić, (unknown), Yann Chéli, Arnaud Jacquel, Carmelo Luci, Nathalie Cardot‐Leccia, (unknown), Patricia Abbe, Maéva Gesson, Laura Sormani, Claire Regazzetti, Guillaume E. Béranger, (unknown), Caroline Pons, A. Khemis, Robert Ballotti, Corine Bertolotto, Stéphane Rocchi, Thierry Passeron	123
6	Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells 2018 ·Cell Death and Differentiation ·(unknown), (unknown), Tanesha Naiken, Hanene Bzioueche, Yann Chéli, Guillaume E. Béranger, Emilie Jaune, Florian Rouaud, Nicolas Nottet, Frédéric Reinier, Céline Gaudel, (unknown), Corine Bertolotto, Robert Ballotti	22
7	Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype 2018 ·Genes & Development ·Mickaël Ohanna, Michaël Cerezo, Nicolas Nottet, Karine Bille, (unknown), Guillaume E. Béranger, Baharia Mograbi, Stéphane Rocchi, Laurent Yvan‐Charvet, Robert Ballotti, Corine Bertolotto	59
8	Efficacy and safety data for checkpoint inhibitors in advanced melanoma under real-life conditions: A monocentric study conducted in Nice from 2010 to 2016 2018 ·Annales de Dermatologie et de Vénéréologie ·(unknown), Éric Fontas, (unknown), Philippe Chevallier, (unknown), Guillaume E. Béranger, J.‐P. Lacour, Thierry Passeron, Henri Montaudié	4
9	Focus on cutaneous and uveal melanoma specificities 2017 ·Genes & Development ·(unknown), Guillaume E. Béranger, J. C. Leclerc, Robert Ballotti, Corine Bertolotto	80
10	White-to-brite conversion in human adipocytes promotes metabolic reprogramming towards fatty acid anabolic and catabolic pathways 2016 ·Molecular Metabolism ·Valentin Barquissau, Diane Beuzelin, Didier F. Pisani, Guillaume E. Béranger, Aline Mairal, Alexandra Montagner, Benoit D. Roussel, Geneviève Tavernier, (unknown), Cédric Moro, Hervé Guillou, Ez‐Zoubir Amri, Dominique Langin	108
11	Let-7i-5p represses brite adipocyte function in mice and humans 2016 ·Scientific Reports ·Maude Giroud, Michael Karbiener, Didier F. Pisani, Rayane A. Ghandour, Guillaume E. Béranger, Tarja Niemi, Markku Taittonen, Pirjo Nuutila, Kirsi A. Virtanen, Dominique Langin, Marcel Scheideler, Ez‐Zoubir Amri	41
12	Pharmacological modulation of LMNA SRSF1-dependent splicing abrogates diet-induced obesity in mice 2016 ·International Journal of Obesity ·(unknown), (unknown), (unknown), Yacine Barèche, Laure Lapasset, Carine Chavey, (unknown), Florence Mahuteau‐Betzer, (unknown), (unknown), Isabel C. López‐Mejía, Guillaume E. Béranger, François Casas, Ez‐Zoubir Amri, Bernard Pau, Didier Scherrer, Jamal Tazi	7
13	Oxytocin Reverses Osteoporosis in a Sex-Dependent Manner 2015 ·Frontiers in Endocrinology ·Guillaume E. Béranger, Mansour Djedaini, (unknown), C. Roux, Marcel Scheideler, Dominique Heymann, Ez‐Zoubir Amri, Didier F. Pisani	29
14	Antagonistic functions of LMNA isoforms in energy expenditure and lifespan 2014 ·EMBO Reports ·Isabel C. López‐Mejía, Marion de Toledo, Carine Chavey, Laure Lapasset, Patricia Cavelier, (unknown), Karim Chébli, Philippe Fort, Guillaume E. Béranger, Lluís Fajas, Ez‐Zoubir Amri, François Casas, Jamal Tazi	48
15	The ω6-fatty acid, arachidonic acid, regulates the conversion of white to brite adipocyte through a prostaglandin/calcium mediated pathway 2014 ·Molecular Metabolism ·Didier F. Pisani, Rayane A. Ghandour, Guillaume E. Béranger, Pauline Le Faouder, Jean‐Claude Chambard, Maude Giroud, Alexandros Vegiopoulos, Mansour Djedaini, Justine Bertrand‐Michel, Michel Tauc, Stephan Herzig, Dominique Langin, Gérard Ailhaud, Christophe Duranton, Ez‐Zoubir Amri	71
16	Chondrogenic potential of stem cells derived from adipose tissue: A powerful pharmacological tool 2013 ·Biochemical and Biophysical Research Communications ·C. Roux, Didier F. Pisani, (unknown), Mansour Djedaini, Guillaume E. Béranger, Jean‐Claude Chambard, Damien Ambrosetti, Jean‐François Michiels, Véronique Breuil, Gérard Ailhaud, Liana Euller‐Ziegler, Ez‐Zoubir Amri	25
17	In vitro brown and “brite”/“beige” adipogenesis: Human cellular models and molecular aspects 2012 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Guillaume E. Béranger, Michael Karbiener, Valentin Barquissau, Didier F. Pisani, Marcel Scheideler, Dominique Langin, Ez‐Zoubir Amri	41
18	Monocytes differentiation upon treatment with a peptide corresponding to the C‐terminus of activated T cell‐expressed Tirc7 protein 2011 ·Journal of Cellular Physiology ·(unknown), Guillaume E. Béranger, Heidy Schmid‐Antomarchi, Danielle Quincey, David Momier, Florian Boukhechba, Georges F. Carle, Nathalie Rochet, Jean‐Claude Scimeca	1
19	Cloning and Use of a Coral 36B4 Gene to Study the Differential Expression of Coral Genes Between Light and Dark Conditions 2008 ·Marine Biotechnology ·Aurélie Moya, Sylvie Tambutté, Guillaume E. Béranger, (unknown), Jean‐Claude Scimeca, Denis Allemand, Didier Zoccola	25
20	Specific Expression of BMP2/4 Ortholog in Biomineralizing Tissues of Corals and Action on Mouse BMP Receptor 2008 ·Marine Biotechnology ·Didier Zoccola, Aurélie Moya, Guillaume E. Béranger, Éric Tambutté, Denis Allemand, Georges F. Carle, Sylvie Tambutté	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact